Literature DB >> 19912204

70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation.

Thorsten Bach1, Nina Huck, Felix Wezel, Axel Häcker, Andreas J Gross, Maurice Stephan Michel.   

Abstract

OBJECTIVE: To evaluate the ablative and haemostatic properties of the recently introduced 120-W thulium:yttrium-aluminium-garnet (Tm-YAG) laser and to assess these results against those of the previously introduced 70-W Tm-YAG laser.
MATERIALS AND METHODS: The ex-vivo model of the isolated blood-perfused porcine kidney was used to determine the ablation capacity, haemostatic properties and coagulation depth of a 2 microm continuous-wave Tm-YAG laser. The energy was delivered using a 550-microm and an 800-microm bare-ended fibre. The results of the recently introduced 120-W Tm-YAG were compared to the established 70-W device. Kidney tissue was embedded for histological evaluation. After staining (haematoxylin and eosin, H & E; and NADH) of the specimen, the coagulation zone and depth of the necrotic tissue layer were measured.
RESULTS: With increased power output, the mean (sd) rate of vaporization of tissue increased, from 9.80 (3.03) g/10 min at 70 W to 16.41 (5.2) g/10 min at 120 W using the 550 microm fibre. The total amount of ablated tissue using the 800 microm fibre was lower than with the 550 microm fibre. With increasing power output the bleeding rate remained stable in either group. Tissue penetration remained shallow, even with increasing power output. In contrast to H&E staining, where the coagulation zone was measured, NADH staining showed an inner zone of necrotic tissue, again with no difference between the 70- and the 120-W Tm-YAG.
CONCLUSION: The 120-W Tm-YAG offers significantly higher ablation rates than the 70-W device, and despite the increased rate of ablation with the 120-W Tm-YAG, the bleeding rate and depth of tissue penetration were comparable to those using the 70-W device.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912204     DOI: 10.1111/j.1464-410X.2009.09059.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  28 in total

1.  Comprehensive analytical model for CW laser induced heat in turbid media.

Authors:  Hakan Erkol; Farouk Nouizi; Alex Luk; Mehmet Burcin Unlu; Gultekin Gulsen
Journal:  Opt Express       Date:  2015-11-30       Impact factor: 3.894

2.  Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.

Authors:  Hai-bin Wei; Jian Zhuo; Xiao-wen Sun; Kun Pang; Yi Shao; Sheng-jie Liang; Di Cui; Fu-jun Zhao; Jun-jie Yu; Shu-jie Xia
Journal:  Lasers Med Sci       Date:  2013-09-12       Impact factor: 3.161

3.  Impact of 120-W 2-μm continuous wave laser vapoenucleation of the prostate on sexual function.

Authors:  Yubin Wang; Jinkai Shao; Yongning Lu; Yongan Lü; Xiaodong Li
Journal:  Lasers Med Sci       Date:  2013-07-05       Impact factor: 3.161

4.  Efficacy and safety of prostate vaporesection using a 120-W 2-μm continuous-wave Tm:YAG laser (RevoLix 2) in patients on continuous oral anticoagulant or antiplatelet therapy.

Authors:  Luciano Macchione; Giuseppe Mucciardi; Alessandro Gali'; Antonina Di Benedetto; Salvatore Butticè; Carlo Magno
Journal:  Int Urol Nephrol       Date:  2013-07-27       Impact factor: 2.370

Review 5.  Thulium: YAG 2 mum cw laser prostatectomy: where do we stand?

Authors:  T Bach; S J Xia; Y Yang; S Mattioli; G M Watson; A J Gross; T R W Herrmann
Journal:  World J Urol       Date:  2010-03-05       Impact factor: 4.226

6.  Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?

Authors:  Esteban Emiliani; Thomas R W Herrmann; Alberto Breda
Journal:  World J Urol       Date:  2015-02-22       Impact factor: 4.226

Review 7.  Nomenclature in thulium laser treatment of benign prostatic hyperplasia: it's time to pull the rabbit out of the hat.

Authors:  Serena Maruccia; Irene Fulgheri; Emanuele Montanari; Stefano Casellato; Luca Boeri
Journal:  Lasers Med Sci       Date:  2021-01-03       Impact factor: 3.161

8.  Natural orifice (NOTES) transurethral sutureless radical prostatectomy with thulium laser support: first patient report.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Ute Walcher; Andre P Nicklas; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2011-07-08       Impact factor: 4.226

9.  Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach.

Authors:  C Netsch; T Bach; T R W Herrmann; O Neubauer; A J Gross
Journal:  World J Urol       Date:  2012-06-24       Impact factor: 4.226

10.  Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.

Authors:  César Vargas; Alejandro García-Larrosa; Santiago Capdevila; Ainhoa Laborda
Journal:  J Endourol       Date:  2014-03-31       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.